Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. M.A.T.M. (Marcel) van Vugt
University Medical Center Groningen

prof. dr. M.A.T.M. (Marcel) van Vugt

Hoogleraar Moleculaire Oncologie, bestuur Comprehensive Cancer Center UMCG

Publicaties

CIP2A mediates mitotic recruitment of SLX4/MUS81/XPF to resolve replication stress-induced DNA lesions

Cyclin E1 overexpression triggers interferon signaling and is associated with antitumor immunity in breast cancer

IFN-I signaling enhances salivary gland stem and progenitor cell activity after irradiation

MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage

WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress response

Acute multi-level response to defective de novo chromatin assembly in S-phase

cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer

Erratum: Acute multi-level response to defective de novo chromatin assembly in S-phase (Molecular Cell (2024) 84(24) (4711–4728.e10), (S1097276524008633), (10.1016/j.molcel.2024.10.023))

EXO1 protects BRCA1-deficient cells against toxic DNA lesions

FIRRM and FIGNL1: partners in the regulation of homologous recombination

Pers/media

Evolutie in het klein: hoe kankercellen zich aanpassen om te overleven

UMCG krijgt miljoen euro voor onderzoek naar therapie bij agressieve borstkanker

University of Groningen: Vici grants for two Groningen-based researchers

Twee Groningse onderzoekers krijgen forse subsidies

Miljoenen voor UMCG-onderzoek naar vroeg opsporen van astma en 'de achilleshiel' van kankercellen

Gelauwerde proefschriften met Poolse samenvattingen